FULL PAPER
3
3
(400 MHz, CDCl3): δ = 7.82 (d, JH,H = 8 Hz, 2 H), 7.21 (d, JH,H
(s, CH3, CH3–Ar cymene), 14.0 (s, CH3, butyl) ppm. 31P{1H}
NMR (162 MHz, CDCl3): δ = 73.5 (s) ppm. HRMS (FAB+): m/z
calcd. for C32H38ClNO2PRuS: 668.1093 [M + H]+; found 668.1097.
1
2
= 8 Hz, 2 H), 6.36 (dt, JH,P = 441, JH,H = 4 Hz, 1 H, PH), 2.63
(t, 3JH,H = 7 Hz, 2 H, Ar–CH2–CH2–CH2–CH3), 2.23 (m, 2 H, CH
isopropyl), 1.58 (m, 2 H, Ar–CH2–CH2–CH2–CH3), 1.33 (m, 2 H,
Ar–CH2–CH2–CH2–CH3), 1.24 (m, 12 H, CH3 isopropyl), 0.91 (t,
3JH,H = 7 Hz, 3 H, Ar–CH2–CH2–CH2–CH3) ppm. 13C{1H} NMR
(101 MHz, CDCl3): δ = 145.8 (s), 142.9 (s), 128.2 (s), 125.6 (s), 34.2
(d, 1JP,C = 211 Hz), 23.8 (s), 23.1 (s), 22.1 (s), 16.4 (s), 15.4 (d, 2JP,C
= 4 Hz), 13.8 (s) ppm. 31P NMR (162 MHz, CDCl3): δ = 36.9 (m,
1JH,P = 441 Hz) ppm.
Complex 7: Obtained in 98% yield from ligand 1B. 1H NMR
(400 MHz, CD2Cl2): δ = 7.82–7.39 (aromatic region, 12 H), 7.11 (d,
3JH,H = 8.0 Hz, 2 H, tolyl aromatic CH), 5.70 (m, 3JH,H = 6.3 Hz, 1
3
H, Arcymene CH), 5.42 (d.m., JH,H = 6.3 Hz, 1 H, Arcymene CH),
3
3
5.230 (d.m., JH,H = 5.8 Hz, 1 H, Arcymene CH), 4.80 (m, JH,H
=
5.8 Hz, 1 H, Arcymene CH), 2.49 (m, 1 H, isopropyl cymene CH),
3
2.31 (s, 3 H), 2.07 (s, 3 H), 1.24 (d, JH,H = 6.9 Hz, 3 H, isopropyl
3
CH3), 1.16 (d, JH,H = 6.9 Hz, 3 H, isopropyl CH3) ppm. 31P{1H}
Synthesis of 3 (mixture of diastereoisomers): Ligand 1F (1 equiv.,
0.15 mmol) and [Ru(H)(Cl)(PPh3)3(CO)] (1 equiv., 0.15 mmol) were
heated at reflux overnight in toluene (5 mL) under nitrogen. The
solvent was removed by vacuum and the residue was dissolved in
diethyl ether (2 mL). Hexane (8 mL) was added and the solution
was kept at –20 °C overnight, thus leading to a yellow precipitate
that was filtered and washed with hexane (10 mL). Complex 3 was
obtained in 35% yield. Slow evaporation of a saturated solution of
complex 3 in diethyl ether resulted in the formation of yellow crys-
tals suitable for X-ray analysis after one week at room temp. 1H
NMR (400 MHz, CDCl3): δ = 8.21–6.94 (aromatic region, 38 H),
2.71–2.53 (4 H, Ar–CH2–CH2–CH2–CH3 both diastereoisomers),
2.20–2.02 (alkyl region, 2 H), 1.67–0.67 (alkyl region, 42 H) ppm.
NMR (162 MHz, CD2Cl2): δ = 73.3 (s) ppm. 13C{1H} NMR
1
(101 MHz, CD2Cl2): δ = 142.5 (d, JP,C = 59.5 Hz, Cquat, phenyl),
3
142.4 (s, Cquat, tolyl C–Me), 140.0 (d, JP,C = 3.7 Hz, Cquat, C–S),
1
134.0 (d, JP,C = 67.4 Hz, Cquat, phenyl), 132.4 (d, JP,C = 11.2 Hz,
CH, phenyl), 130.9 (d, JP,C = 2.9 Hz, CH, phenyl), 130.6 (d, JP,C
=
11.2 Hz, CH, phenyl), 130.4 (d, JP,C = 2.7 Hz, CH, phenyl), 129.3
(s, CH, tolyl), 129.1 (d, JP,C = 10.9 Hz, CH, phenyl), 128.4 (d, JP,C
= 11.7 Hz, CH, phenyl), 127.9 (s, CH, tolyl), 105.7 (s, Cquat
,
2
cymene), 95.3 (d, JP,C = 6.3 Hz, CH, cymene), 94.0 (s, Cquat
,
2
2
cymene), 86.9 (d, JP,C = 6.9 Hz, CH, cymene), 86.1 (d, JP,C
=
2
3.3 Hz, CH, cymene), 82.6 (d, JP,C = 2.9 Hz, CH, cymene), 31.1
(s, CH, cymene), 22.6 (s, CH3), 22.2 (s, CH3), 21.6 (s, CH3), 18.8
(s, CH3, CH3–Ar cymene) ppm. HRMS (ESI+): m/z calcd. for
C29H32ClNO2PRuS: 626.06234 [M + H]+; found 626.06409.
31P{1H} NMR (162 MHz, CDCl3): δ = 100.0 (d, JP,P = 25.5 Hz,
diastereoisomer a), 97.7 (d, JP,P = 24.0 Hz, diastereoisomer b),
2
2
39.1 (d, 2JP,P = 24.0 Hz, diastereoisomer b), 37.4 (d, 2JP,P = 25.5 Hz,
diastereoisomer a) ppm. Ratio of diastereoisomer a/b = 1.7 After
purification, based on 31P integrals. HRMS (ESI+): m/z calcd. for
C70H86Cl2N2O6P4Ru2S2: 1512.23418 [M·]+; found 1512.23667.
Heterolytic Cleavage of H2 Using 7 to Yield Complex 10: Method
A: Complex 7 (1 equiv., 12.5 μmol), KPF6 (10 equiv., 125 μmol),
and [D8]THF (0.5 mL) were charged in a high-pressure NMR spec-
troscopy tube. The tube was pressurized with hydrogen (10 bar),
1
stirred, and sonicated for 4 days. H NMR (400 MHz, [D8]THF):
General Synthesis of Piano-Stool Complexes: Ligand 1 (2 mmol,
1 equiv.) and [{RuCl(cymene)(μ-Cl)}2] (2 mmol, 1 equiv.) were dis-
solved in THF (20 mL) at room temperature. Triethylamine (1 mL)
was added, and the solution was stirred at room temperature for
2 h. The solution was filtered, and the THF was evaporated. The
residue was dissolved in dichloromethane (5 mL) and diethyl ether
(35 mL) was added dropwise, thus leading to an orange precipitate.
The precipitate was filtered and washed with diethyl ether (10 mL).
3
δ = 7.94 (m, 2 H, phenyl C–H), 7.85 (d, JP,H = 10.7 Hz, 1 H, N–
H), 7.79 (m, 2 H, phenyl C–H), 7.42–7.32 (6 H, phenyl C–H), 6.96
3
3
(d, JH,H = 8.2 Hz, 2 H, tolyl C–H), 6.89 (d, JH,H = 8.2 Hz, 2 H,
tolyl C–H), 5.63 (d, JH,H = 6.2 Hz, 1 H, Arcymene C–H), 5.39 (d,
JH,H = 5.8 Hz, 1 H, Arcymene C–H), 4.72 (d, JH,H = 6.2 Hz, 1 H,
Arcymene C–H), 4.54 (s, dissolved H2), 4.39 (d, JH,H = 5.8 Hz, 1 H,
Arcymene C–H), 2.25 (s, 3 H), 1.84 (m, 1 H, isopropyl cymene C–
3
H), 1.80 (s, 3 H), 0.98 (d, JH,H = 5.0 Hz, 3 H, isopropyl cymene
3
Complex 6: Obtained in 93% yield from ligand 1A. For crystalli-
zation, a solution of 6 (20 mg) in THF (0.2 mL) was layered with
diethyl ether (1 mL) to give a red crystalline material (suitable for
CH3), 0.96 (d, JH,H = 5.0 Hz, 3 H, isopropyl cymene CH3), –8.34
(d, J = 52.5 Hz, 1 H) ppm. 31P NMR (162 MHz, [D8]THF): δ =
87.7 (m, JP,H = 52 Hz) ppm. Method B: Complex 7 (1 equiv.,
X-ray analysis) after two weeks of slow diffusion at room temp. 1H 125 μmol) and KPF6 (2 equiv., 250 μmol) were suspended in THF
3
NMR (400 MHz, CDCl3): δ = 7.86–7.36 (12 H), 7.08 (d, JH,H
=
(2 mL). The solution was charged into an autoclave and submitted
8.3 Hz, 2 H, CH), 5.68 (d, 3JH,H = 6.3 Hz, 1 H, Arcymene CH), 5.40 to H2 (50 bar) for 10 h. After depressurizing to ambient conditions,
(d, JH,H = 6.4 Hz, 1 H, Arcymene CH), 5.26 (m, JH,H = 5.8 Hz, 1 the solution was filtered and the solvent was evaporated. The resi-
H, Arcymene CH), 4.83 (m, JH,H = 5.7 Hz, 1 H, Arcymene CH), 2.59 due was dissolved in dichloromethane and filtered with an HPLC
(m, 1 H, iPrCymene CH), 2.54 [t, JH,H = 7.0 Hz, 2 H, Ar–CH2– filter. The solvent was evaporated to yield complex 10 in quantita-
3
3
3
3
(CH2)2–CH3], 2.12 (s, 3 H, CH3 cymene), 1.50 (m, 2 H, Ar–CH2– tive yield. Method C: Complex 7 (1 equiv., 12.5 μmol) was dissolved
CH2–CH2–CH3), 1.32–1.18 [8 H, isopropyl cymene CH3 and Ar–
in THF (0.5 mL) and submitted to an atmosphere of H2 (50 bar)
3
(CH2)2–CH2–CH3] 0.87 (t, JH,H = 7.3 Hz, 3 H, butyl CH3) ppm. in an autoclave/NMR spectroscopy tube for 10 h. After depressur-
13C{1H} NMR (101 MHz, CDCl3): δ = 146.7 (s, Cquat, bu-
izing to ambient conditions, the solvent was evaporated to yield
1
3
1
tylphenyl), 142.2 (d, JP,C = 60.0 Hz, Cquat, phenyl), 139.1 (d, JP,C
complex 10 in quantitative yield. H NMR (400 MHz, CD2Cl2): δ
1
= 3.6 Hz, Cquat, butylphenyl), 133.1 (d, JP,C = 67.3 Hz, Cquat
phenyl), 132.2 (d, JP,C = 11.3 Hz, CH, phenyl), 130.627 (d, JP,C
,
=
= 7.92 (dd, JP,H = 11.5, JH,H = 7.5 Hz, 2 H, phenyl C–H), 7.76 (dd,
2
JP,H = 12.0, JH,H = 7.1 Hz, 2 H, phenyl C–H), 7.57 (d, JP,H
=
2.7 Hz, CH, phenyl), 130.4 (d, JP,C = 11.4 Hz, CH, phenyl), 130.047
(d, JP,C = 2.8 Hz, CH, phenyl), 128.7 (d, JP,C = 10.8 Hz, CH,
phenyl), 128.7 (s, CH, butylphenyl), 128.0 (d, JP,C = 11.8 Hz, CH,
10.9 Hz, 1 H, N–H), 7.48–7.35 (6 H), 6.96 (d, 3JH,H = 8.2 Hz, 2 H,
tolyl C–H), 6.91 (d, JH,H = 8.2 Hz, 2 H, tolyl C–H), 5.61 (d, JH,H
3
= 6.2 Hz, 1 H, Arcymene C–H), 5.36 (d, JH,H = 5.9 Hz, 1 H, Arcymene
phenyl), 127.9 (s, CH, butylphenyl), 105.090 (s, Cquat, cymene), C–H), 4.69 (d, JH,H = 6.2 Hz, 1 H, Arcymene C–H), 4.28 (d, J =
2
94.614 (d, JP,C = 6.2 Hz, CH, cymene), 93.4 (s, Cquat, cymene),
5.8 Hz, 1 H, Arcymene C–H), 2.28 (s, 3 H), 1.83 (s, 3 H), 1.81 (m, 1
2
2
3
86.5 (d, JP,C = 6.9 Hz, CH, cymene), 86.0 (d, JP,C = 3.2 Hz, CH,
cymene), 83.2 (d, 2JP,C = 3.2 Hz, CH, cymene), 35.6 (s, CH2, butyl),
33.4 (s, CH2, butyl), 30.7 (s, CH, cymene), 22.4 (s, CH3, CH3–CH
H, isopropyl cymene C–H), 0.99 (d, JH,H = 7.0 Hz, 6 H), –8.45
2
(d, JP,H = 52.0 Hz, 1 H) ppm. 31P NMR (162 MHz, CD2Cl2): δ =
2
89.2 (m, JP,H = 52.0 Hz) ppm. 13C{1H} NMR (75 MHz, CD2Cl2):
cymene), 22.3 (s, CH2, butyl), 22.3 (s, CH3, CH3–CH cymene), 18.7 δ = 143.1 (s, Cquat, tolyl C–Me), 139.5 (s, Cquat, tolyl C–Me), 136.0
Eur. J. Inorg. Chem. 2014, 1826–1835
1833
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim